默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRK 默沙东

已收盘 05-22 16:00:00 EDT

77.84

+0.86

+1.12%

盘后77.92

+0.08+0.10%

19:56 EDT

最高78.36	最低76.68	成交量1,180万
今开76.72	昨收76.98	日振幅2.18%
总市值1,955亿	流通市值1,952亿	总股本25.11亿
成交额9.16亿	换手率0.47%	流通股本25.07亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":77.84,"timestamp":1747944000000,"preClose":76.98,"halted":0,"volume":11799971,"hourTrading":{"tag":"盘后","latestPrice":77.92,"preClose":77.84,"latestTime":"19:56 EDT","volume":622441,"amount":48451262.5526,"timestamp":1747958187264},"delay":0,"floatShares":2507088180,"shares":2511031253,"eps":6.878679,"marketStatus":"已收盘","change":0.86,"latestTime":"05-22 16:00:00 EDT","open":76.72,"high":78.36,"low":76.68,"amount":916118124.51772,"amplitude":0.021824,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.878679,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1747987200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":-745790400000,"exchange":"NYSE","adjPreClose":76.98,"dividendRate":0.040082,"preHourTrading":{"tag":"盘前","latestPrice":77.01,"preClose":76.98,"latestTime":"09:29 EDT","volume":13269,"amount":1022074.4475600001,"timestamp":1747920580118},"postHourTrading":{"tag":"盘后","latestPrice":77.92,"preClose":77.84,"latestTime":"19:56 EDT","volume":622441,"amount":48451262.5526,"timestamp":1747958187264},"volumeRatio":0.879006,"impliedVol":0.3873,"impliedVolPercentile":0.88},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2535475518","title":"默沙东(MRK.US)畅销药物Keytruda于卵巢癌晚期试验达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2535475518","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535475518?lang=zh_cn&edition=full","pubTime":"2025-05-15 20:15","pubTimestamp":1747311318,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，默沙东周四宣布，其最畅销的治疗药物Keytruda作为联合治疗方案的一部分，在一项针对特定类型卵巢癌的3期试验中达到了主要终点。该公司指出，该数据首次表明基于keytruda的治疗方案延长了PROC患者的生存期。抗PD -1疗法尚未被批准用于卵巢癌。至于KEYNOTE-B96的耐受性数据，默沙东表示，Keytruda的安全性与之前的研究结果一致，没有新的安全性信号。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293774.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0965509283.SGD","BK4533","LU1093756168.USD","SG9999014542.SGD","LU1989771016.USD","LU0265550946.USD","LU1069347547.HKD","LU0208291251.USD","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU1934455194.USD","LU2023250504.SGD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU1162221912.USD","SG9999014559.SGD","SG9999001440.SGD","LU1585245621.USD","IE00BLSP4452.SGD","LU2112291526.USD","LU1037948897.HKD","BK4550","LU0238689110.USD","LU1989772840.SGD","LU1093756325.SGD","SG9999013999.USD","SG9999014567.USD","LU0203345920.USD","LU0070302665.USD","LU1057294990.SGD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU1934455277.USD","LU1983299246.USD","LU2023250843.SGD","IE00B2B36J28.USD","MRK","IE00BLSP4239.USD","LU0320765646.SGD","SG9999001176.USD","LU1989772923.USD","BK4559","IE00BFTCPJ56.SGD","LU0985320562.USD","SG9999015358.SGD","BK4516","LU1066051498.USD"],"gpt_icon":1},{"id":"2535702713","title":"花旗将制药商默沙东的评级从“买入”下调至“中性”，目标价从115美元下调至84美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535702713","media":"金融界","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535702713?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:22","pubTimestamp":1747228920,"startTime":"0","endTime":"0","summary":"花旗将制药商默沙东的评级从“买入”下调至“中性”，目标价从115美元下调至84美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14212250393699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01477","MRK"],"gpt_icon":0},{"id":"2535022434","title":"花旗下调默沙东评级至“中性” 目标价降至84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535022434","media":"格隆汇","labels":["rating"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535022434?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:09","pubTimestamp":1747228161,"startTime":"0","endTime":"0","summary":"花旗将制药商默沙东的评级从“买入”下调至“中性”，目标价从115美元下调至84美元。该行指，担心Keytruda将于2028年失去独家销售权，这可能导致销售额下降10%-20%。(格隆汇)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/14210950393551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"rating","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRK"],"gpt_icon":0},{"id":"2535463620","title":"实现中国本土包装首发，新型抗菌药物锐可博获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2535463620","media":"广州日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535463620?lang=zh_cn&edition=full","pubTime":"2025-05-14 17:42","pubTimestamp":1747215742,"startTime":"0","endTime":"0","summary":"默沙东日前宣布，其新型碳青霉烯/酶抑制剂复合制剂锐可博?（注射用亚胺西瑞）已正式在中国上市，适用于治疗18岁及以上患者由敏感革兰阴性菌引起的下列感染：医院获得性细菌性肺炎和呼吸机相关性细菌性肺炎；治疗药物选择有限或无替代治疗的复杂性尿路感染（包括肾盂肾炎）；治疗药物选择有限或无替代治疗的复杂性腹腔内感染。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202505143404510879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0058720904.USD","IE0002141913.USD","LU2361044949.HKD","IE00BJT1NW94.SGD","LU0965509283.SGD","LU1917777945.USD","LU0203347892.USD","IE00BLSP4452.SGD","BK4550","LU1934455194.USD","LU2361044865.SGD","MRK","LU0320765489.SGD","LU0320765646.SGD","LU1585245621.USD","LU0265550946.USD","LU1162221912.USD","LU0985320562.USD","LU0211331839.USD","LU2023250843.SGD","BK4588","SG9999014567.USD","LU1116320737.USD","LU0234572021.USD","BK4585","LU2361045086.USD","LU1989772923.USD","LU2106854487.HKD","SG9999013999.USD","LU1066051225.USD","LU1929549753.HKD","LU1069347547.HKD","LU2112291526.USD","LU1037948897.HKD","SG9999002224.SGD","LU0122379950.USD","LU1941712264.USD","IE00B1BXHZ80.USD","BK4533","IE0009355771.USD","LU0861579265.USD","LU0203345920.USD","LU1983299246.USD","IE000M9KFDE8.USD","LU1023059063.AUD","LU2023250504.SGD","LU0106261372.USD","LU1035773651.USD","BK4559","IE00B4R5TH58.HKD"],"gpt_icon":1},{"id":"2535090653","title":"默沙东/科伦博泰 TROP2 ADC 又双叒叕启动 III 期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2535090653","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535090653?lang=zh_cn&edition=full","pubTime":"2025-05-14 15:02","pubTimestamp":1747206169,"startTime":"0","endTime":"0","summary":"5 月 13 日，ClinicalTrials 网站显示，默沙东登记了一项比较 Sac-TMT联合帕博利珠单抗和卡铂/紫杉醇对比化疗联合帕博利珠单抗新辅助治疗高危、早期三阴性乳腺癌或激素受体低阳性/人表皮生长因子受体 2 阴性乳腺癌的 III 期临床研究。Insight 数据库显示，这是默沙东针对该药启动的第 14 项全球多中心临床试验，此前还有 13 项临床试验，涉及卵巢癌、宫颈癌、胃癌、非小细胞肺癌、子宫内膜癌等。该药首次于 2024 年 11 月获 NMPA 批准上市，用于三阴性乳腺癌的二线治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514152826a6de97f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514152826a6de97f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1929549753.HKD","LU0320765489.SGD","LU0965509010.AUD","IE0002141913.USD","SG9999001176.USD","SG9999014575.USD","LU0203345920.USD","LU1093756325.SGD","LU1116320737.USD","LU1037948541.HKD","BK4516","III","LU2468319806.SGD","LU1917777945.USD","MRK","SG9999014559.SGD","LU1571399168.USD","SG9999002232.USD","LU1989772923.USD","LU0320765646.SGD","LU0965509101.SGD","BK4533","IE00BN8TJ469.HKD","ADC","LU1162221912.USD","SG9999001440.SGD","LU1093756168.USD","LU0208291251.USD","SG9999015358.SGD","LU1430594728.SGD","SGXZ57979304.SGD","LU1037948897.HKD","LU1941712264.USD","LU1989771016.USD","SG9999013999.USD","SG9999015341.SGD","LU0006306889.USD","LU2324357040.USD","BK4559","LU0122379950.USD","LU0265550359.USD","LU0965508806.USD","LU1989772840.SGD","LU0211331839.USD","LU2089984988.USD","IE0009355771.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","BK4534","LU1023059063.AUD"],"gpt_icon":1},{"id":"2535229867","title":"硕腾一季报；默沙东动保宣布近9亿美元投资项目丨宠业简报","url":"https://stock-news.laohu8.com/highlight/detail?id=2535229867","media":"宠业家","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535229867?lang=zh_cn&edition=full","pubTime":"2025-05-13 17:30","pubTimestamp":1747128653,"startTime":"0","endTime":"0","summary":"2025年第一季度，来自伴侣动物产品的营收高达14.5亿美元，占总营收比重超65%。宠业简报02默沙东动保宣布近9亿美元投资项目外媒报道，默沙东动物保健公司计划斥资8.95亿美元扩建其位于美国堪萨斯州De Soto市的制造工厂和研发园区。这项为期多年的项目预计将为堪萨斯城动物健康走廊提供2500个建筑岗位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513194345a47caf38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513194345a47caf38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2089984988.USD","IE00BLSP4239.USD","LU1116320737.USD","LU0158827948.USD","LU0965509010.AUD","LU2468319806.SGD","SG9999014575.USD","LU1934455194.USD","LU1057294990.SGD","LU0345774631.USD","LU2461242641.AUD","MRK","LU2361044949.HKD","LU0238689110.USD","SGXZ57979304.SGD","LU1941712264.USD","LU0058720904.USD","LU2361045086.USD","LU0006306889.USD","IE00BSNM7G36.USD","SG9999014567.USD","ZTS","LU0234572021.USD","LU0265550946.USD","IE00B19Z9505.USD","LU2106854487.HKD","SG9999013999.USD","LU2111349929.HKD","LU1066053197.SGD","BK4585","LU1699723380.USD","IE0002141913.USD","SG9999001176.SGD","LU0106261372.USD","LU2324357040.USD","BK4533","LU0965509101.SGD","SG9999015358.SGD","LU0861579265.USD","LU2023251221.USD","SG9999015341.SGD","LU1066051811.HKD","IE00B4R5TH58.HKD","LU2023250843.SGD","BK4516","LU0471298694.HKD","BK4550","LU0208291251.USD","SG9999014542.SGD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2535933737","title":"诺和诺德长效生长激素III期研究成功；默沙东新型抗菌药物锐可博在华上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2535933737","media":"Ofweek维科网","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535933737?lang=zh_cn&edition=full","pubTime":"2025-05-13 13:53","pubTimestamp":1747115623,"startTime":"0","endTime":"0","summary":"默沙东新型抗菌药在国内上市。双方将共同开发创新型多肽药物，应用于体重控制等代谢性疾病治疗领域。5）默沙东新型抗菌药物锐可博在华上市5月12日，默沙东宣布，其新型碳青霉烯/酶抑制剂复合制剂锐可博已正式在中国境内上市，适用于治疗18岁及以上患者由敏感革兰阴性菌引起的多项感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505131353509757fa49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505131353509757fa49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1162221912.USD","LU1116320737.USD","LU1989772923.USD","BK4550","LU2023250843.SGD","LU0266013472.USD","LU0208291251.USD","BK4134","LU1057294990.SGD","IE00BSNM7G36.USD","SG9999014542.SGD","LU2089984988.USD","SG9999014559.SGD","LU2461242641.AUD","IE0009355771.USD","BK4599","LU0985320562.USD","IE00B1BXHZ80.USD","BK4585","LU0965509010.AUD","LU2361044949.HKD","LU1066053197.SGD","BK4007","SG9999014567.USD","LU0965508806.USD","LU1989772840.SGD","MRK","BK4588","LU0289739699.SGD","IE00BBT3K403.USD","LU0058720904.USD","LU0320765646.SGD","LU0006306889.USD","LU1061106388.HKD","LU1934455194.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1037948541.HKD","LU0238689110.USD","LU1291159041.SGD","LU1983299246.USD","LU2324357040.USD","NVO","LU2361044865.SGD","IE00BJT1NW94.SGD","LU0203347892.USD","LU1989771016.USD","LU1116320901.HKD","LU0211331839.USD","III"],"gpt_icon":1},{"id":"2535984201","title":"默沙东上涨5.03%，报79.795美元/股，总市值2003.68亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535984201","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535984201?lang=zh_cn&edition=full","pubTime":"2025-05-13 00:06","pubTimestamp":1747065974,"startTime":"0","endTime":"0","summary":"5月13日，默沙东(MRK)盘中上涨5.03%，截至00:06，报79.795美元/股，成交8.19亿美元，总市值2003.68亿美元。财务数据显示，截至2025年03月31日，默沙东收入总额155.29亿美元，同比减少1.56%；归母净利润50.79亿美元，同比增长6.66%。资料显示，默克公司是一家领先的全球生物制药公司,它一直致力于为世界上许多最具挑战性的疾病提供药物和疫苗。如今,默克继续处于生物制药研究的最前沿,以推动预防和治疗威胁世界各地人民的疾病——包括癌症,心脏疾病,新出现的动物疾病,阿尔茨海默和包括艾滋和埃博拉在内的传染病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/13000650325881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1023059063.AUD","LU1066051498.USD","IE00B2B36J28.USD","LU0234572021.USD","LU0861579265.USD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU1430594728.SGD","BK4559","LU0106261372.USD","LU1069347547.HKD","LU0320765489.SGD","SG9999014567.USD","LU0985320562.USD","LU1989772840.SGD","LU0289739699.SGD","LU1093756168.USD","LU0122379950.USD","IE0002141913.USD","LU1989771016.USD","LU0265550359.USD","LU0203345920.USD","IE00BN8TJ469.HKD","IE00BBT3K403.USD","LU1941712264.USD","LU1061106388.HKD","LU1066051811.HKD","LU2106854487.HKD","LU1941712348.USD","LU0238689110.USD","LU0965508806.USD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU2468319806.SGD","LU0058720904.USD","LU0965509101.SGD","LU2023250504.SGD","SG9999002224.SGD","LU2023250843.SGD","LU0265550946.USD","LU2361044865.SGD","LU1116320737.USD","LU0211331839.USD","LU1037948541.HKD","BK4516","MRK","SG9999001176.USD","SG9999014542.SGD","LU1974910355.USD","BK4550"],"gpt_icon":0},{"id":"2534425342","title":"默沙东新型抗菌药物锐可博（注射用亚胺西瑞）在华上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2534425342","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534425342?lang=zh_cn&edition=full","pubTime":"2025-05-12 17:32","pubTimestamp":1747042346,"startTime":"0","endTime":"0","summary":"格隆汇5月12日｜默沙东宣布，其新型碳青霉烯/酶抑制剂复合制剂锐可博（注射用亚胺西瑞）已正式在中国境内上市，适用于治疗18岁及以上患者由敏感革兰阴性菌引起的下列感染：医院获得性细菌性肺炎和呼吸机相关性细菌性肺炎（HABP/VABP）；治疗药物选择有限或无替代治疗的复杂性尿路感染（cUTI）（包括肾盂肾炎）；治疗药物选择有限或无替代治疗的复杂性腹腔内感染（cIAI）。据悉，首批药物已在默沙东中国杭州工厂完成包装，实现本土首发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505121816359757173a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505121816359757173a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0070302665.USD","IE0002141913.USD","LU1061106388.HKD","LU1116320901.HKD","LU1989772840.SGD","LU1066051811.HKD","LU1941712348.USD","IE00BJJMRZ35.SGD","LU0203347892.USD","LU0238689110.USD","MRK","LU1037948541.HKD","SG9999002232.USD","SG9999001440.SGD","LU1066051498.USD","SG9999002224.SGD","SG9999014559.SGD","LU1093756168.USD","LU1037948897.HKD","IE00BJT1NW94.SGD","LU1585245621.USD","LU0211331839.USD","LU0234572021.USD","SG9999014567.USD","LU0965509283.SGD","LU1941712264.USD","LU2361044949.HKD","LU1571399168.USD","LU1983299246.USD","IE00B4R5TH58.HKD","LU1430594728.SGD","BK4550","SG9999013999.USD","SG9999015341.SGD","IE00BN8TJ469.HKD","IE00BLSP4452.SGD","LU2461242641.AUD","SGXZ57979304.SGD","LU1917777945.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU2023250504.SGD","LU0965509101.SGD","LU1057294990.SGD","LU0058720904.USD","SG9999014575.USD","LU1934455194.USD","SG9999015358.SGD","LU0203345920.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"1157589110","title":"特朗普：将签署行政令，药价将立即降低30%-80%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157589110","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157589110?lang=zh_cn&edition=full","pubTime":"2025-05-12 07:13","pubTimestamp":1747005195,"startTime":"0","endTime":"0","summary":"美国总统特朗普就美国高药价问题在其社媒发帖称，多年来，制药/药品公司总是声称这是研发成本所致，而且毫无缘由地，所有这些成本都将由美国的“冤大头”独自承担。政治献金能创造“奇迹”，但对我以及共和党来说却行不通。我们要做正确的事，因此，我很高兴地宣布，明天上午9点（北京时间周一21点），我将在白宫签署一项美国历史上影响极为深远的行政命令。处方药和药品价格几乎会立即下降30%至80%。全球药价将会上涨以达到平衡，多年来首次为美国带来公平！我将推行“最惠国”政策，据此美国将支付与世界上支付最低价格的国家相同的价格。此前，特朗普预告，其将发布最重要、最具影响力的内容之一。","market":"sh","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"613df4b61bc3692be0fcc4204cdfad36","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash.jin10.com/detail/20250512063138170800","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jssj","symbols":["PFE","LLY","JNJ","MRNA","NVS","NVAX","MRK","NVO"],"gpt_icon":0},{"id":"2534444524","title":"全球药王易主！3 个月爆卖 600 亿，这一次司美真的登顶了…","url":"https://stock-news.laohu8.com/highlight/detail?id=2534444524","media":"华尔街见闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534444524?lang=zh_cn&edition=full","pubTime":"2025-05-10 19:36","pubTimestamp":1746877004,"startTime":"0","endTime":"0","summary":"2025 年第一局，司美正式反超 K 药，登上全球“药王”的宝座。但是，药王宝座也不是轻松就能坐稳的。回顾历任药王，最大杀手，莫过于失去了专利保护。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/b7482e21-02ea-4feb-9085-afa144e4bd5a.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/b7482e21-02ea-4feb-9085-afa144e4bd5a.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3746841","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3746841","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"全球药王易主！3 个月爆卖 600 亿，这一次司美真的登顶了…","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["LU2468319806.SGD","LU1291159041.SGD","BK4007","LU1941712264.USD","SGXZ57979304.SGD","LU1917777945.USD","LU1974910355.USD","BK4533","SG9999015341.SGD","LU1035773651.USD","LU1934455194.USD","LU0965509010.AUD","LU1093756325.SGD","LU2361044949.HKD","BK4532","LU0234572021.USD","BK4534","LU1066053197.SGD","LU0106261372.USD","LU1069347547.HKD","LU1699723380.USD","LU2023250504.SGD","NVO","SG9999002224.SGD","IE00BLSP4452.SGD","LU2361044865.SGD","LU1023059063.AUD","LU1037948897.HKD","BK4516","SG9999014575.USD","LU1037948541.HKD","IE0002141913.USD","SG9999015358.SGD","BK4550","LU0320765489.SGD","LU0070302665.USD","LU1093756168.USD","LU2112291526.USD","IE00BN8TJ469.HKD","IE0009355771.USD","LU1116320737.USD","LU2106854487.HKD","LU2461242641.AUD","LU1430594728.SGD","LU0006306889.USD","MRK","IE00BKVL7J92.USD","BK4559","IE00B2B36J28.USD","LU0965509283.SGD"],"gpt_icon":1},{"id":"2533294323","title":"默沙东，中国区大幅下跌62%的背后是什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2533294323","media":"药闻康策","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533294323?lang=zh_cn&edition=full","pubTime":"2025-05-08 00:01","pubTimestamp":1746633715,"startTime":"0","endTime":"0","summary":"2025年，默沙东发布的财报显示，其中国区销售额同比骤降62%，创下近十年最大跌幅。此外，信达生物的PD-1/VEGF双抗药物凭借适应症拓展，直接冲击默沙东的联合用药市场。产品管线依赖与创新断层默沙东中国区收入仍依赖Keytruda等成熟产品，占其总营收的60%，而2025年其管线中仅有一款针对肝癌的TIGIT抑制剂获批，远落后于国内药企在ADC、双抗等领域的密集突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508043244a6d6bf7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508043244a6d6bf7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999002232.USD","LU0006306889.USD","LU0320765646.SGD","LU0266013472.USD","LU0965509010.AUD","SGXZ57979304.SGD","LU0265550946.USD","LU0861579265.USD","LU0985320562.USD","LU0203345920.USD","LU2324357040.USD","LU0965508806.USD","IE00BN8TJ469.HKD","IE00BFTCPJ56.SGD","LU1934455863.HKD","SG9999001176.SGD","IE00BJJMRZ35.SGD","IE00BLSP4452.SGD","BK4007","LU1037948541.HKD","LU1069347547.HKD","BK4550","IE00B1BXHZ80.USD","LU0203347892.USD","LU0965509283.SGD","LU2089984988.USD","LU1037948897.HKD","SG9999014559.SGD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU0211331839.USD","LU1571399168.USD","IE00BBT3K403.USD","LU1929549753.HKD","LU1699723380.USD","LU1934455277.USD","LU0122379950.USD","LU1934455194.USD","LU1989771016.USD","LU1989772840.SGD","LU1023059063.AUD","LU1974910355.USD","LU0265550359.USD","MRK","LU2361045086.USD","LU1291159041.SGD","LU0289739699.SGD","LU1093756325.SGD","SG9999002224.SGD","SG9999001440.SGD"],"gpt_icon":1},{"id":"2533398464","title":"司美格鲁肽登顶药王！诺和诺德、默沙东一季报揭晓战略分野","url":"https://stock-news.laohu8.com/highlight/detail?id=2533398464","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533398464?lang=zh_cn&edition=full","pubTime":"2025-05-07 19:33","pubTimestamp":1746617619,"startTime":"0","endTime":"0","summary":"当前，诺和诺德糖尿病业务的支柱产品已经由胰岛素变更为现象级产品GLP-1。HPV疫苗下降四成对于去年险胜司美格鲁肽，而在今年一季度便丢掉“药王”宝座的K药，业界原本便抱有一定预期。其中，默沙东的制药业务收入为136.38亿美元，同比下降1%，原因是受疫苗、抗病毒、免疫等板块拖累。默沙东业绩下滑的主要原因仍要归咎于HPV疫苗Gardasil/Gardasil 9。默沙东表示，Gardasil/Gardasil 9的销售额下滑主要是由于中国地区需求下降，库存仍居高不下。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507194813a6d651a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507194813a6d651a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1974910355.USD","LU0070302665.USD","LU1291159041.SGD","LU1023059063.AUD","LU1035773651.USD","IE00BSNM7G36.USD","LU2023250843.SGD","LU2089984988.USD","SG9999002232.USD","LU1037948541.HKD","IE00B1BXHZ80.USD","SG9999001176.USD","LU0208291251.USD","SG9999014559.SGD","SG9999013999.USD","BK4532","LU1934455194.USD","BK4588","LU0861579265.USD","LU2324357040.USD","IE00BBT3K403.USD","LU1983299246.USD","IE00BN8TJ469.HKD","BK4550","LU1585245621.USD","SG9999014542.SGD","LU0058720904.USD","BK4585","IE00BZ1G4Q59.USD","BK4599","SG9999014567.USD","LU2361045086.USD","IE000M9KFDE8.USD","MRK","LU0203347892.USD","LU0965509283.SGD","BK4559","SG9999001176.SGD","LU0289739699.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","SG9999001440.SGD","LU1699723380.USD","LU0266013472.USD","LU1929549753.HKD","LU0965509101.SGD","LU2112291526.USD","NVO","BK4534","LU2361044865.SGD"],"gpt_icon":1},{"id":"2533967262","title":"司美格鲁肽全球销售额超过抗癌药物K药 暂时坐上了全球“药王”宝座","url":"https://stock-news.laohu8.com/highlight/detail?id=2533967262","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533967262?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:10","pubTimestamp":1746609016,"startTime":"0","endTime":"0","summary":"2025年第一季度，司美格鲁肽全球销售额终于超过K药，暂时坐上了全球“药王”宝座。诺和诺德在一季报中表示，全球约有10亿人患有肥胖症，但只有数百万人接受治疗，公司继续在全球推广Wegovy。不过，司美格鲁肽仍要直面与礼来的GLP-1/GIP双重激动剂替尔泊肽的竞争，且两者的竞争日趋白热化。\n\n\r\n            责任编辑：山上","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/05/07171050194878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["SG9999001176.USD","MRK","LU0208291251.USD","SG9999014542.SGD","LU1162221912.USD","LU1974910355.USD","LU2361045086.USD","LU1035773651.USD","LU2361044949.HKD","LU0265550946.USD","LU2324357040.USD","SG9999014575.USD","LU1037948897.HKD","LU1430594728.SGD","LU1934455277.USD","SG9999015341.SGD","LU1066051498.USD","LU1929549753.HKD","LU2468319806.SGD","IE00BBT3K403.USD","SG9999015358.SGD","LU1989772840.SGD","LU0238689110.USD","IE00BSNM7G36.USD","LU0006306889.USD","SG9999002224.SGD","LU1941712348.USD","LU0320765646.SGD","IE00BFTCPJ56.SGD","LU2023250843.SGD","SG9999013999.USD","LU0965509101.SGD","LU1989772923.USD","BK4559","LU0203345920.USD","LU1699723380.USD","LU2112291526.USD","LU0965509010.AUD","IE00B4R5TH58.HKD","LU1934455194.USD","LU2106854487.HKD","LU1983299246.USD","LU1116320901.HKD","LU1037948541.HKD","LU1571399168.USD","LU1066051811.HKD","LU0266013472.USD","SG9999001176.SGD","LU0122379950.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2533665674","title":"司美格鲁肽全球销售额超过抗癌药物K药 暂时坐上了全球“药王”宝座","url":"https://stock-news.laohu8.com/highlight/detail?id=2533665674","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533665674?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:02","pubTimestamp":1746608529,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2471134796.USD","BK4534","MRK","LU0211331839.USD","LU1974910355.USD","BK4590","BK4581","LU1291159041.SGD","LU1929549753.HKD","SGXZ99366536.SGD","LU0061475181.USD","LU1623119135.USD","GLP","LU0256863902.USD","LU2237443382.USD","LU2361044865.SGD","SG9999014906.USD","LLY","LU1868836591.USD","SG9999014542.SGD","LU0094547139.USD","LU2211815571.USD","SGXZ57979304.SGD","LU0640476718.USD","IE00BLSP4452.SGD","LU1551013342.USD","LU1064131342.USD","LU1720051017.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1934455277.USD","LU0203202063.USD","BK4516","LU0965508806.USD","LU1989771016.USD","BK4550","NVO","LU0417517546.SGD","LU1069344957.HKD","LU2237438978.USD","LU0471298694.HKD","LU2750360641.GBP","LU0320765059.SGD","LU1548497426.USD","LU2471134523.USD","LU2023250843.SGD","LU1035775433.USD","SGXZ51526630.SGD","LU2552382132.HKD","LU0096364046.USD"],"gpt_icon":0},{"id":"2533674179","title":"一季度药物市场激战：司美格鲁肽收入超80亿美元力压K药，预定“药王”桂冠","url":"https://stock-news.laohu8.com/highlight/detail?id=2533674179","media":"21财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533674179?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:01","pubTimestamp":1746608498,"startTime":"0","endTime":"0","summary":"一季度，诺和诺德司美格鲁肽合计收入569.34亿丹麦克朗，同比增长31%，这一业绩高于礼来的替尔泊肽。根据5月1日礼来公司发布的第一季度业绩报告，礼来公司第一季度营收127.29亿美元，同比增长45%；净利润27.59亿美元，同比增长23%。礼来替尔泊肽双靶点药物、诺和诺德口服司美格鲁肽剂型有望成为两家跨国巨头的新增长极。第一季度，司美格鲁肽的合计收入已超越默沙东的帕博利珠单抗（K药），有望夺得2025年度“药王”宝座。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050717015394ef0dac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050717015394ef0dac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0154236417.USD","LU1093756325.SGD","IE00BN8TJ469.HKD","BK4599","LU0203347892.USD","LU1057294990.SGD","LU1989772923.USD","LU0122379950.USD","LU0265550359.USD","LU1061106388.HKD","LU2106854487.HKD","LU1934455194.USD","LU2461242641.AUD","LU0289739699.SGD","LU1929549753.HKD","LU1066051225.USD","LU1989771016.USD","SG9999014559.SGD","NVO","LU1934455863.HKD","LU0234572021.USD","LU1066053197.SGD","IE000M9KFDE8.USD","BK4559","LU1941712348.USD","LU2361045086.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0965509010.AUD","LU1069347547.HKD","LU1116320901.HKD","LU1974910355.USD","LU2361044865.SGD","MRK","SG9999015341.SGD","LU2112291526.USD","LU1116320737.USD","LU2468319806.SGD","LU0965509101.SGD","LU2324357040.USD","LU0861579265.USD","SG9999001176.USD","LU1037948897.HKD","IE00B2B36J28.USD","IE0009355771.USD","LU0006306889.USD","LU1430594728.SGD","LU1093756168.USD","IE00BFTCPJ56.SGD"],"gpt_icon":1},{"id":"2531703906","title":"默沙东研发（中国）有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2531703906","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531703906?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:27","pubTimestamp":1745998045,"startTime":"0","endTime":"0","summary":"4月30日，据CDE官网消息，默沙东研发（中国）有限公司联合申请药品“注射用MK-2870”，获得临床试验默示许可，受理号CXSB2500040。公示信息显示，药品“注射用MK-2870”适应症：非小细胞肺癌。默沙东研发（中国）有限公司，成立于2012年，位于北京市，是一家以从事研究和试验发展为主的企业。企业注册资本2000万美元，实缴资本2000万美元。通过天眼查大数据分析，默沙东研发（中国）有限公司参与招投标项目9次，专利信息3条，此外企业还拥有行政许可7个。主要股东信息显示，默沙东研发（中国）有限公司由默沙东研发有限公司持股100%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/30152750039951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SG9999002224.SGD","BK1576","LU0965508806.USD","LU1291159041.SGD","SG9999014567.USD","IE00BFTCPJ56.SGD","03347","LU0070302665.USD","LU1057294990.SGD","SG9999014575.USD","LU0106261372.USD","LU0203347892.USD","IE00BLSP4452.SGD","LU1093756325.SGD","LU1989772840.SGD","LU0861579265.USD","LU1941712264.USD","LU1066053197.SGD","LU2461242641.AUD","LU1023059063.AUD","LU2089984988.USD","LU0320765646.SGD","LU0058720904.USD","BK4585","LU2023250843.SGD","LU0122379950.USD","LU0965509283.SGD","LU1037948897.HKD","LU1917777945.USD","MRK","IE00B1BXHZ80.USD","SG9999014542.SGD","LU1941712348.USD","LU1066051811.HKD","BK4533","LU1974910355.USD","BK4534","BK4007","LU1035773651.USD","LU1571399168.USD","BK4516","LU2023250504.SGD","IE00BN8TJ469.HKD","BK4588","LU0265550359.USD","LU0211331839.USD","LU1116320737.USD","SG9999001176.USD","LU0289739699.SGD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2531788875","title":"默沙东(MRK.US)拟斥资10亿美元在美国建厂 以确保Keytruda供应免受关税冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=2531788875","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531788875?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:28","pubTimestamp":1745922508,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据报道，默沙东 正寻求在特拉华州投资10亿美元建立工厂，扩大其在美国的制造业务。随着针对行业的关税迫在眉睫，默沙东成为最新一家增加美国国内投资的制药公司。但这款占默沙东近半数营收的药物，预计将在2028年面临低价竞争和政府定价谈判。默沙东预计将于今年晚些时候推出一款更易于使用的Keytruda版本，以期保住原研药30%至40%的市场份额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"默沙东(MRK.US)拟斥资10亿美元在美国建厂 以确保Keytruda供应免受关税冲击","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4516","BK4550","LU1941712348.USD","LU0208291251.USD","IE00BLSP4452.SGD","SG9999001440.SGD","LU2461242641.AUD","LU1093756325.SGD","SG9999014567.USD","SG9999014559.SGD","IE0002141913.USD","LU0006306889.USD","LU1941712264.USD","LU0203347892.USD","LU1037948897.HKD","LU1934455277.USD","LU1037948541.HKD","SG9999015341.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","IE000M9KFDE8.USD","LU1934455194.USD","LU0265550946.USD","SG9999001176.SGD","BK4585","SG9999002232.USD","LU1974910355.USD","LU0234572021.USD","LU0965509010.AUD","LU1989772840.SGD","MRK","BK4588","LU0320765489.SGD","SGXZ57979304.SGD","LU1929549753.HKD","LU1162221912.USD","LU1430594728.SGD","SG9999014575.USD","LU1057294990.SGD","SG9999014542.SGD","BK4007","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU0266013472.USD","IE00BJT1NW94.SGD","BK4533","LU1066051811.HKD","LU1917777945.USD","SG9999002224.SGD","LU1035773651.USD"],"gpt_icon":0},{"id":"2530288734","title":"每日全球并购：默克收购SpringWorks进入后期谈判 | 中润光学收购戴斯光电控股权（4/28）","url":"https://stock-news.laohu8.com/highlight/detail?id=2530288734","media":"晨哨并购","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530288734?lang=zh_cn&edition=full","pubTime":"2025-04-28 20:36","pubTimestamp":1745843760,"startTime":"0","endTime":"0","summary":"-每日资讯-1、默克收购SpringWorks进入后期谈判德国默克公司正在与美国SpringWorks Therapeutics就收购事宜进行后期谈判，交易金额约35亿美元。默克有望通过此次收购获得一种新批准的罕见疾病药物，并扩大其癌症治疗产品组合。此次收购将是默克近年来最大的制药交易之一，旨在推动其癌症治疗业务的发展。SpringWorks于2019年上市，专注于罕见癌症和遗传疾病的药物开发，其疗法Ogsiveo已获美国批准用于治疗硬纤维瘤，基因疾病药物gomez kli也于今年2月获批。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-28/doc-ineutqhq5074247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2361045086.USD","688307","SG9999014542.SGD","LU0265550946.USD","LU0058720904.USD","LU1069347547.HKD","LU1929549753.HKD","LU0208291251.USD","IE000M9KFDE8.USD","LU0289739699.SGD","LU1061106388.HKD","IE00BBT3K403.USD","LU1934455194.USD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU2468319806.SGD","SG9999014559.SGD","SG9999001440.SGD","LU1585245621.USD","LU0965509010.AUD","LU1116320901.HKD","LU1037948897.HKD","SG9999002232.USD","LU0238689110.USD","SG9999013999.USD","BK4007","LU0266013472.USD","LU1291159041.SGD","LU1934455277.USD","IE00BN8TJ469.HKD","LU1983299246.USD","LU2361044865.SGD","MRK","IE00B2B36J28.USD","IE0009355771.USD","LU0203347892.USD","LU0965508806.USD","SG9999001176.USD","LU1989772923.USD","BK4534","LU1571399168.USD","BK4559","IE00BFTCPJ56.SGD","LU1699723380.USD","LU0965509101.SGD","LU0234572021.USD","LU2089984988.USD","LU1066051498.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"1133351274","title":"高盛：美股医药股Q1业绩令人欣慰，行业情绪略微趋于积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1133351274","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133351274?lang=zh_cn&edition=full","pubTime":"2025-04-28 17:44","pubTimestamp":1745833489,"startTime":"0","endTime":"0","summary":"在某些情况下甚至优于预期。","market":"us","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1286394.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BMY","MRK","JNJ"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":0.0478},{"period":"1month","weight":-0.0112},{"period":"3month","weight":-0.122},{"period":"6month","weight":-0.2238},{"period":"1year","weight":-0.4113},{"period":"ytd","weight":-0.2262}],"compareEarnings":[{"period":"1week","weight":-0.008},{"period":"1month","weight":0.1342},{"period":"3month","weight":-0.0451},{"period":"6month","weight":-0.0212},{"period":"1year","weight":0.0969},{"period":"ytd","weight":-0.0055}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.009524},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.001865},{"month":3,"riseRate":0.622222,"avgChangeRate":-0.002869},{"month":4,"riseRate":0.608696,"avgChangeRate":0.017086},{"month":5,"riseRate":0.630435,"avgChangeRate":0.016214},{"month":6,"riseRate":0.511111,"avgChangeRate":0.01265},{"month":7,"riseRate":0.488889,"avgChangeRate":0.003443},{"month":8,"riseRate":0.488889,"avgChangeRate":0.001677},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.006327},{"month":10,"riseRate":0.533333,"avgChangeRate":0.018591},{"month":11,"riseRate":0.711111,"avgChangeRate":0.028573},{"month":12,"riseRate":0.6,"avgChangeRate":0.013993}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.5","shortVersion":"4.33.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}